4.8 Article

Capabilities of hepatitis B surface antigen are divergent from hepatitis B virus DNA in delimiting natural history phases of chronic hepatitis B virus infection

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B

Robin Erken et al.

Summary: Integrated HBV levels are closely related to clinical outcomes in patients with chronic hepatitis B and can be quantified. Integrated HBV levels are correlated with surrogate markers for virological activity, but not with cccDNA levels, and can predict HBsAg loss.

HEPATOLOGY (2022)

Review Immunology

Immunobiology and pathogenesis of hepatitis B virus infection

Matteo Iannacone et al.

Summary: HBV is a hepatotropic virus that can cause persistent infection and serious liver diseases. Immune responses, particularly CD8(+) T cells, play a crucial role in viral clearance and liver pathology.

NATURE REVIEWS IMMUNOLOGY (2022)

Article Biochemical Research Methods

Quantitative serum HBV markers in predicting phases of natural history of chronic HBV infection

Zhan-qing Zhang et al.

Summary: This study evaluated the clinical value of commercially available quantitative HBV markers for predicting different phases of chronic HBV infection. The results demonstrated that HBsAg and anti-HBc are reliable markers for predicting active hepatitis, while HBcrAg and HBV DNA are preferred markers for predicting inactive hepatitis. The established models MEPAH and MENAH have good performance in predicting the respective phases of hepatitis.

JOURNAL OF VIROLOGICAL METHODS (2021)

Review Gastroenterology & Hepatology

Chronic hepatitis B: the demise of the 'inactive carrier' phase

Apostolos Koffas et al.

Summary: Chronic hepatitis B remains a global healthcare burden, with reductions in incidence but ongoing challenges with liver cirrhosis and hepatocellular carcinoma. Advances in understanding the immunopathogenesis of CHB have led to changes in clinical categorization, encouraging a lower treatment threshold and a 'Treat All' approach.

HEPATOLOGY INTERNATIONAL (2021)

Review Virology

HBV-Integration Studies in the Clinic: Role in the Natural History of Infection

Teresa Pollicino et al.

Summary: Hepatitis B virus (HBV) infection is a major global health issue that can cause acute and chronic liver diseases, including cirrhosis and hepatocellular carcinoma. HBV DNA integration into the host genome is essential for viral replication and establishment of chronic infection, and also plays a role in liver tumorigenesis.

VIRUSES-BASEL (2021)

Article Medicine, General & Internal

Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection

Zhanqing Zhang et al.

Summary: Quantitative HBsAg is more valuable than HBV DNA in predicting significant hepatitis activity of HBeAg-positive chronic HBV infection, with higher sensitivity and specificity levels.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Gastroenterology & Hepatology

Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load

Marie-Anne Meier et al.

Summary: Integrated HBV DNA can contribute to HBsAg production independently of viral replication, and transcribed HBV integration can extend to the entire liver in some HBe-negative patients, leading to ubiquitous HBsAg expression. This questions the clinical utility of HBsAg as a surrogate marker for viral replication in patients with low serum viral loads.

JOURNAL OF HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression

Arshi Khanam et al.

Summary: This review discusses the current knowledge of innate and adaptive immune cell transformations associated with immunopathogenesis and disease outcome in chronic hepatitis B patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Virology

Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management

Alicia Vachon et al.

Summary: Despite the lack of predictive markers for guiding clinical management and allowing treatment cessation with reduced risk of viral reactivation, the development of novel HBV biomarkers is helping to improve the management of individuals with chronic hepatitis B. The utility of these biomarkers in both treatment-naive and treated CHB patients has been widely discussed.

VIRUSES-BASEL (2021)

Review Microbiology

The Hepatitis B Virus Interactome: A Comprehensive Overview

Ellen Van Damme et al.

Summary: Chronic hepatitis B, caused by HBV, is a major health issue globally, with the goal of treatment being functional cure. Understanding the virus's biology is crucial for identifying new therapeutic targets in order to achieve high rates of functional cure.

FRONTIERS IN MICROBIOLOGY (2021)

Review Gastroenterology & Hepatology

Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad

Marc G. Ghany et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients

Zhan-qing Zhang et al.

GASTROENTEROLOGIA Y HEPATOLOGIA (2020)

Article Gastroenterology & Hepatology

Viral hepatitis in children and adolescents 1 Hepatitis B virus infection in children and adolescents

Giuseppe Indolfi et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Norah A. Terrault et al.

HEPATOLOGY (2018)

Review Virology

Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks

Patrick T. F. Kennedy et al.

VIRUSES-BASEL (2017)

Article Gastroenterology & Hepatology

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

S. K. Sarin et al.

HEPATOLOGY INTERNATIONAL (2016)

Article Gastroenterology & Hepatology

HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant

William S. Mason et al.

GASTROENTEROLOGY (2016)

Editorial Material Gastroenterology & Hepatology

'Immune tolerance' in HBV infection: danger lurks

Wai-Kay Seto et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Serum hepatitis B surface antigen levels in the natural history of chronic hepatitis B infection

J. W. Jang et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)

Article Gastroenterology & Hepatology

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia

Tin Nguyen et al.

JOURNAL OF HEPATOLOGY (2010)

Review Gastroenterology & Hepatology

Grading and staging systems for inflammation and fibrosis in chronic liver diseases

Zachary D. Goodman

JOURNAL OF HEPATOLOGY (2007)

Review Gastroenterology & Hepatology

Management of hepatitis B: Summary of a clinical research workshop

Jay H. Hoofnagle et al.

HEPATOLOGY (2007)

Review Gastroenterology & Hepatology

Hepatitis B e antigen-negative chronic hepatitis B: Natural history and treatment

SJ Hadziyannis et al.

SEMINARS IN LIVER DISEASE (2006)

Review Gastroenterology & Hepatology

Hepatitis B e antigen-negative chronic hepatitis B

SJ Hadziyannis et al.

HEPATOLOGY (2001)

Review Gastroenterology & Hepatology

Management of hepatitis B: 2000 - Summary of a workshop

AS Lok et al.

GASTROENTEROLOGY (2001)